Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
+651K
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$8.71M
-
Number of buys
-
22
-
Number of sells
-
-27
-
Price
-
$13.24
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2017
53 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2017.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
of 55.5M outstanding shares and own 19.93% of the company stock.
Largest 10 shareholders include FMR LLC (3.76M shares), Bain Capital Public Equity Management, LLC (1.51M shares), Partner Fund Management, L.P. (1.5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares), BlackRock Inc. (536K shares), Casdin Capital, LLC (500K shares), VANGUARD GROUP INC (418K shares), EVENTIDE ASSET MANAGEMENT, LLC (300K shares), STATE STREET CORP (165K shares), and JPMORGAN CHASE & CO (163K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.